STAT3 and endometrial cancer: Previous studies have implicated the STAT3 pathway as a key dysregulated pathway in cancer as evidenced by its constitutive tyrosine phosphorylation in glioma, as well as in breast, colon, kidney and endometrial cancers [10, 18–21].